{'fraction_non_alphanumeric': 0.04573804573804574, 'fraction_numerical': 0.002079002079002079, 'mean_word_length': 5.426666666666667, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Reply to Letter to the Editors: "Prognostic value of B-type natriuretic peptide in liver transplant patients".

We appreciate Jin and Li for their interest in our recent research (1), which emphasizes the B-type natriuretic peptide (BNP) screening, rather than diagnosing heart failure itself, in predicting mortality after liver transplant (LT). However, Jin and Li may have misinterpreted our research or misunderstood patients' characteristics of end-stage liver disease (ESLD).